320 related articles for article (PubMed ID: 34659118)
1. Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia.
Asadi F; Dhanvantari S
Front Endocrinol (Lausanne); 2021; 12():726368. PubMed ID: 34659118
[TBL] [Abstract][Full Text] [Related]
2. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.
Omar-Hmeadi M; Lund PE; Gandasi NR; Tengholm A; Barg S
Nat Commun; 2020 Apr; 11(1):1896. PubMed ID: 32312960
[TBL] [Abstract][Full Text] [Related]
3. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
4. Glucagon secretion from pancreatic α-cells.
Briant L; Salehi A; Vergari E; Zhang Q; Rorsman P
Ups J Med Sci; 2016 May; 121(2):113-9. PubMed ID: 27044683
[TBL] [Abstract][Full Text] [Related]
5. Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
Chen W; Cui W; Wu J; Zheng W; Sun X; Zhang J; Shang H; Yuan Y; Li X; Wang J; Hu X; Chen L; Zeng F; Xiao RP; Zhang X
Metabolism; 2023 Sep; 146():155641. PubMed ID: 37380017
[TBL] [Abstract][Full Text] [Related]
6. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
7. Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
Honzawa N; Fujimoto K; Kitamura T
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357734
[TBL] [Abstract][Full Text] [Related]
8. Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia.
Dusaulcy R; Handgraaf S; Skarupelova S; Visentin F; Vesin C; Heddad-Masson M; Reimann F; Gribble F; Philippe J; Gosmain Y
Endocrinology; 2016 Oct; 157(10):3832-3843. PubMed ID: 27547850
[TBL] [Abstract][Full Text] [Related]
9. The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror.
Martínez MS; Manzano A; Olivar LC; Nava M; Salazar J; D'Marco L; Ortiz R; Chacín M; Guerrero-Wyss M; Cabrera de Bravo M; Cano C; Bermúdez V; Angarita L
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502413
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166
[TBL] [Abstract][Full Text] [Related]
11. Alpha cell dysfunction in type 1 diabetes.
Yosten GLC
Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
[TBL] [Abstract][Full Text] [Related]
12. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
Cryer PE
Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
[TBL] [Abstract][Full Text] [Related]
13. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
14. Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.
Meier JJ; Ueberberg S; Korbas S; Schneider S
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E717-23. PubMed ID: 21285404
[TBL] [Abstract][Full Text] [Related]
15. Glucagon and type 2 diabetes: the return of the alpha cell.
Lund A; Bagger JI; Christensen M; Knop FK; Vilsbøll T
Curr Diab Rep; 2014 Dec; 14(12):555. PubMed ID: 25344790
[TBL] [Abstract][Full Text] [Related]
16. The role of GIP in α-cells and glucagon secretion.
El K; Campbell JE
Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.
Kawamori D; Welters HJ; Kulkarni RN
Adv Exp Med Biol; 2010; 654():421-45. PubMed ID: 20217508
[TBL] [Abstract][Full Text] [Related]
18. Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes.
Asadi F; Dhanvantari S
Islets; 2022 Dec; 14(1):40-57. PubMed ID: 34923907
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
20. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
Gilon P
J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
